News About: Pharm. Industry
What are the government’s plans for investment into new drug in 2018?
The government is planning to enlarge support for new drug development in the initial phase, reduce the support in the commercialization phase, like Phase 3 clinical trials, and promote investments into private compan...
Can the rest of companies not indicted be relieved from the rebate case of the hospital located in Jeonju?
While the rebate case of the hospital ‘J’ located in Jeonju is about to be finished, the Ministry of Food and Drug Safety(MFDS) has appeared as an unexpected enemy.
According to the industry concerned, the prosecutio...
Busan Eastern DPO completed rebate & drug price investigations
As Busan Eastern District Prosecutor’s Office(DPO) announced a result of the investigation in which the office has conducted towards pharmaceutical companies, doctors and hospitals, a number of pharmaceutical companie...
No. of employees in pharma industry reaches close to 100 thousand
The number of employees working in the pharmaceutical industry has reached close to 100 thousand people.
In the circumstance where the domestic market and investment have been depressed, the entire industries in Kore...
‘PharmaTech Business Center’ consisting of 77 people from 40 companies to be established
At the Geranium Hall of Hotel Samjung Seoul at 13:20 on the 28th of February, the Korea Drug Research Association(President Dong-Yeon Kim, hereinafter referring to KDRA) will held the ‘Inauguration Ceremony of the 17t...
Yuhan, Chong Kun Dang and Hanmi’s outpatient prescriptions increased by over 10%
Last January, outpatient prescriptions were analyzed to record KRW 959.8 billion increased by 5.9% compared to the last year. Among the top pharmaceutical companies, moreover, Yuhan Corporation, Chong Kun Dang and Han...
Kolmar Korea distributes Twynsta-referencing first generic ‘Telopine Tab’ to 20 pharmas
Kolmar Korea, a global CMO(contract manufacturing organization), announced on the 22nd that it has succeeded in developing ‘Telopine Tab,’ the first generic referencing the top sales drug in the antihypertensive marke...
Pharmas share COD(collect on delivery) expenses with distribution companies
While the pharmaceutical distribution industry is experiencing difficulties, such as unacceptance and delay over returns of disused and stored drugs, pharmaceutical companies have caused an issue again as shifting exp...
HIRA holds the open debate with pharmaceutical industry
In order to communicate with the pharmaceutical industry, the Health Insurance Review & Assessment Service(President Myong-Sei Sohn, hereinafter referring to ‘HIRA’) held a debate with people working in the pharmaceut...
Big5 Pharmas grown externally, but decreased in profitability
As Yuhan Corporation made KRW 1.3308 trillion sales, Korean pharmaceutical companies have externally grown, but it was criticized they lost profitability.
According to the Yakup Shinmoon’s(www.yakup.com) analysis re...
